共 50 条
Incidence of Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates That Test Susceptible to Cephalosporins and Aztreonam by the Revised CLSI Breakpoints
被引:10
|作者:
McWilliams, Carla S.
[1
]
Condon, Susan
[2
]
Schwartz, Rebecca M.
[3
,4
]
Ginocchio, Christine C.
[2
,4
]
机构:
[1] North Shore LIJ Hlth Syst, Dept Med, Div Infect Dis, Manhasset, NY USA
[2] North Shore LIJ Hlth Syst Labs, Dept Pathol & Lab Med, Lake Success, NY USA
[3] North Shore LIJ Hlth Syst, Dept Populat Hlth, Great Neck, NY USA
[4] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA
关键词:
PIPERACILLIN-TAZOBACTAM;
CEFEPIME THERAPY;
ENTEROBACTERIACEAE;
INFECTIONS;
IMPACT;
D O I:
10.1128/JCM.03613-13
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
The incidence of aztreonam and cephalosporin susceptibility, determined using the revised CLSI breakpoints, for extendedspectrum-beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates was evaluated. Our analysis showed that results for aztreonam and/or> 1 cephalosporin were reported as susceptible or intermediate for 89.2% of ESBLproducing E coli isolates (569/638 isolates) and 67.7% of ESBL-producing K. pneumoniae isolates (155/229 isolates).
引用
收藏
页码:2653 / 2655
页数:3
相关论文